Rankings
▼
Calendar
RCKT Q1 2016 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$538M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$10M
Net Income
-$10M
EPS (Diluted)
$-1.52
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$486,000
Balance Sheet
Total Assets
$104M
Total Liabilities
$5M
Stockholders' Equity
$99M
Cash & Equivalents
$59M
← FY 2016
All Quarters
Q2 2016 →
